The CDKL5 kinase undergoes liquid-liquid phase separation driven by a serine-rich C-terminal region and impaired by neurodevelopmental disease-related truncations

Marco Dell’Oca,Stefania Boggio Bozzo,Serena Vaglietti,Antonia Gurgone,Vita Cardinale,Gregorio Ragazzini,Andrea Alessandrini,Luca Colnaghi,Mirella Ghirardi,Maurizio Giustetto,Ferdinando Fiumara
DOI: https://doi.org/10.1101/2024.11.18.624084
2024-11-18
Abstract:Mutations of the (CDKL5) gene, which encodes a serine/threonine protein kinase, can cause the (CDD), a severe neurodevelopmental disease characterized by epileptic encephalopathy and neurocognitive impairment. The CDKL5 kinase consists of a catalytic N-terminal domain (NTD) and a less characterized C-terminal domain (CTD). Numerous disease-related mutations truncate CDKL5, leaving the NTD intact while variably shortening the CTD, which highlights the importance of the CTD for CDKL5 function. By systematically analyzing CDKL5 compositional features and evolutionary dynamics, we found that the CTD is a low-complexity region (LCR) highly enriched in serine residues and with a high propensity to undergo liquid-liquid phase separation (LLPS), a biophysical process of condensation controlling protein localization and function. Using a combination of super-resolution imaging, electron microscopy, and molecular and cellular approaches, including optogenetic LLPS induction, we discovered that CDKL5 undergoes LLPS, predominantly driven by its CTD, forming membraneless condensates in neuronal and non-neuronal cells. A CTD internal fragment (CTIF) plays a pivotal LLPS-promoting role, along with the distal portion of the protein. Indeed, two disease-related truncating mutations (S726X and R781X), eliding variable portions of the CTIF, significantly impair LLPS. This impairment is paralleled at the functional level by a reduction in the CDKL5-dependent phosphorylation of EB2, a known CDKL5 target. These findings demonstrate that CDKL5 undergoes LLPS, driven by a CTD region elided by most disease-related truncating mutations. Its loss––through the impairment of CDKL5 LLPS and functional activity––may play a key role in the molecular pathogenesis of CDD.
Molecular Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is related to the function of CDKL5 protein and its mechanism of action in neurodevelopmental disorders. Specifically, the study focused on the role of the C - terminal region (CTD) of CDKL5 protein in the liquid - liquid phase separation (LLPS) process, and how this process is affected by disease - related truncation mutations. ### Research Background The CDKL5 gene encodes a serine/threonine protein kinase, and its mutations can lead to CDKL5 deficiency (CDD), which is a severe neurodevelopmental disorder characterized by epileptic encephalopathy and neurocognitive dysfunction. The CDKL5 protein consists of a catalytic N - terminal domain (NTD) and a less - studied C - terminal domain (CTD). Many disease - related mutations cause truncation of the CDKL5 protein, retaining the NTD while shortening the CTD to varying degrees, indicating that the CTD is crucial for the function of CDKL5. ### Main Problems 1. **Characteristics of CTD**: Study the amino acid composition characteristics of CTD, especially its serine - rich feature, and whether this feature is conserved during evolution. 2. **Mechanism of LLPS**: Explore whether CTD can drive the liquid - liquid phase separation (LLPS) of CDKL5 to form membraneless condensates, and analyze the molecular mechanism of this process. 3. **Impact of Disease - related Mutations**: Evaluate how truncation mutations related to CDD affect the LLPS behavior and functional activity of CDKL5, especially its phosphorylation of EB2. ### Methods and Findings - **Amino Acid Composition Analysis**: Through systematic analysis of the amino acid composition of CDKL5, it was found that CTD is a low - complexity region (LCR), rich in serine, and has a high LLPS propensity. - **Evolutionary Analysis**: By comparing CDKL5 homologs in different species, it was found that the serine - rich property of CTD is highly conserved during evolution, especially more significantly in mammals. - **Cell Experiments**: Using techniques such as immunofluorescence, super - high - resolution imaging, and electron microscopy, it was observed that CDKL5 forms typical LLPS condensates in cells. - **Functional Verification**: By using the optogenetic method (optoDroplet system) to induce LLPS, the crucial role of CTD in this process was further confirmed. In addition, the study found that two disease - related truncation mutations (S726X and R781X) significantly impaired the LLPS behavior of CDKL5 and its ability to phosphorylate EB2. ### Conclusion The research results show that the CTD of CDKL5 is a serine - rich low - complexity region that can drive the liquid - liquid phase separation of the protein to form membraneless condensates. The formation of these condensates is crucial for the function of CDKL5, and the truncation mutations related to CDD affect the functional activity of CDKL5 by impairing the LLPS process, and thus may play a crucial role in the molecular pathogenesis of CDD.